Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 61.54 M69.24 M66.22 M66.89 M69.48 M 271.83 M Research & development ————— — Operating income 73.47 M79.19 M86.51 M65.38 M57.79 M 288.87 M Non-Operating Income, Total 5.72 M13.79 M1.68 M1.42 M6.57 M 23.46 M Interest expense, net of interest capitalized 9.07 M9.47 M9.38 M9.05 M9.11 M 37.01 M Non-Operating Income, excl. Interest Expenses -4.33 M-1.05 M-6.68 M-7.63 M-3.34 M -18.71 M Unusual income/expense 975 K5.37 M-1.02 M—808 K — Pretax income 69.38 M78.42 M79.91 M286.18 M54.83 M 499.33 M Equity in earnings 362 K311 K97 K276 K277 K 961 K Taxes 19 M23.97 M8.62 M-119.45 M18.72 M -68.14 M Non-controlling/minority interest ————— — After tax other income/expense -450 K311 K407 K—-418 K — Net income before discontinued operations 50.38 M54.44 M71.29 M177.65 M36.11 M 339.49 M Discontinued operations ————— — Net income 50.38 M54.44 M71.29 M177.65 M36.11 M 339.49 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 50.38 M54.44 M71.29 M177.65 M36.11 M 339.49 M Basic earnings per share (Basic EPS) 0.50.540.711.780.36 3.39 Diluted earnings per share (Diluted EPS) 0.490.540.711.750.36 3.36 Average basic shares outstanding 100.75 M100.56 M100.02 M100.22 M99.53 M — Diluted shares outstanding 101.9 M101.37 M101.06 M101.26 M100.61 M — EBITDA 94.21 M97.12 M101.72 M76.48 M80.69 M 356 M EBIT 69.76 M75.62 M83.5 M50.2 M53.51 M 262.83 M Cost of revenue 539.61 M549.73 M590.97 M536.3 M565.16 M 2.24 B Other cost of goods sold 10.35 M2.5 M15 M-12.42 M2.6 M 7.68 M Depreciation & amortization (cash flow) 24.45 M25.4 M26.12 M26.28 M27.17 M 104.98 M